Viking Therapeutics, Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Viking Therapeutics, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q1 2019 to Q3 2024.
  • Viking Therapeutics, Inc. Operating Lease, Liability, Noncurrent for the quarter ending September 30, 2024 was $755K, a 25.8% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $755K -$263K -25.8% Sep 30, 2024 10-Q 2024-10-23
Q2 2024 $766K -$334K -30.4% Jun 30, 2024 10-Q 2024-07-24
Q1 2024 $852K -$329K -27.9% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $936K -$324K -25.7% Dec 31, 2023 10-Q 2024-10-23
Q3 2023 $1.02M -$319K -23.9% Sep 30, 2023 10-Q 2023-10-25
Q2 2023 $1.1M -$314K -22.2% Jun 30, 2023 10-Q 2023-07-26
Q1 2023 $1.18M -$309K -20.7% Mar 31, 2023 10-Q 2023-04-26
Q4 2022 $1.26M Dec 31, 2022 10-K 2024-02-07
Q3 2022 $1.34M Sep 30, 2022 10-Q 2022-10-26
Q2 2022 $1.41M Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $1.49M Mar 31, 2022 10-Q 2022-04-27
Q4 2020 $29K -$331K -91.9% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $115K -$323K -73.7% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 $198K -$315K -61.4% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $279K -$309K -52.6% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $360K Dec 31, 2019 10-K 2021-02-17
Q3 2019 $438K Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $513K Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $588K Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.